Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Using mTOR Inhibitors in the Prevention of BK Nephropathy

Not Applicable

Completed

Conditions: BK Nephropathy
BK Viremia

Interventions: Drug: Tacrolimus
Drug: Mycophenolate acid
Drug: Sirolimus

First Posted Date: 2012-07-25

Last Posted Date: 2018-02-28

Lead Sponsor: Columbia University

Target Recruit Count: 40

Registration Number: NCT01649609

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States
🇺🇸
Weill Cornell Medical Center, New York, New York, United States

Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease

Phase 2

Withdrawn

Conditions: Crohn's Disease

Interventions: Drug: Growth Hormone
Dietary Supplement: Nutraceutical Combination
Other: Placebo Growth Hormone
Other: Exclusion Diet

First Posted Date: 2012-07-23

Last Posted Date: 2015-04-13

Lead Sponsor: Columbia University

Registration Number: NCT01647412

Locations: 🇺🇸
Columbia University Department of Clinical Genetics, New York, New York, United States

Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients

Phase 2

Completed

Conditions: Spinal Muscular Atrophy

Interventions: Drug: 4-aminopyridine
Drug: Placebo

First Posted Date: 2012-07-20

Last Posted Date: 2016-05-18

Lead Sponsor: Columbia University

Target Recruit Count: 11

Registration Number: NCT01645787

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

LIFT: Lifestyle Interventions For Two

Not Applicable

Completed

Conditions: Overweight
Pregnancy

Interventions: Behavioral: Intensive Lifestyle Intervention (ILI)
Behavioral: Usual Care

First Posted Date: 2012-06-11

Last Posted Date: 2019-02-01

Lead Sponsor: Columbia University

Target Recruit Count: 210

Registration Number: NCT01616147

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users

Not Applicable

Completed

Conditions: HIV
Substance Abuse
AIDS

Interventions: Behavioral: Retention Clinic

First Posted Date: 2012-06-07

Last Posted Date: 2022-05-12

Lead Sponsor: Columbia University

Target Recruit Count: 360

Registration Number: NCT01614106

Locations: 🇺🇸
Jackson Health System-Special Immunology Clinic, Miami, Florida, United States
🇺🇸
Grady Health System-Ponce De Leon Center, Atlanta, Georgia, United States

Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis

Phase 3

Completed

Conditions: Osteoporosis

Interventions: Drug: Risedronate
Drug: Placebo Teriparatide
Drug: Teriparatide
Drug: placebo Risedronate

First Posted Date: 2012-06-05

Last Posted Date: 2014-03-04

Lead Sponsor: Columbia University

Target Recruit Count: 31

Registration Number: NCT01611571

Locations: 🇺🇸
Columbia University Medical Center, Harkness Pavilion, New York City, New York, United States

Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users

Not Applicable

Completed

Conditions: HIV
Substance Abuse
AIDS
Inpatient

Interventions: Behavioral: Patient Navigator Plus Contingency Management (PN+CM) Group
Behavioral: Patient Navigation (PN) Group

First Posted Date: 2012-06-05

Last Posted Date: 2016-03-14

Lead Sponsor: Columbia University

Target Recruit Count: 801

Registration Number: NCT01612169

Locations: 🇺🇸
University Hospital At University of Alabama, Birmingham (Uab), Birmingham, Alabama, United States
🇺🇸
Saint Luke's Roosevelt Hospital Center, New York, New York, United States
🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

and more 9 locations

Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver Transplant

Phase 2

Conditions: Hepatitis C

Interventions: Drug: Rifaximin
Drug: Placebo

First Posted Date: 2012-05-22

Last Posted Date: 2016-04-22

Lead Sponsor: Columbia University

Target Recruit Count: 59

Registration Number: NCT01603108

Locations: 🇺🇸
Columbia University Medical Center - NYPH, New York, New York, United States

Environmental Intervention Versus Standard Care to Reduce Pharmacologic Therapy for Asthma

Not Applicable

Completed

Conditions: Asthma

Interventions: Other: Environmental Intervention

First Posted Date: 2012-05-07

Last Posted Date: 2022-02-04

Lead Sponsor: Columbia University

Target Recruit Count: 243

Registration Number: NCT01593111

Locations: 🇺🇸
Jacobi Medical Center, Bronx, New York, United States
🇺🇸
Columbia University Medical Center, New York, New York, United States

Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)

Terminated

Conditions: Subarachnoid Hemorrhage (SAH)
Tachycardia

First Posted Date: 2012-04-25

Last Posted Date: 2019-09-10

Lead Sponsor: Columbia University

Target Recruit Count: 1540

Registration Number: NCT01585311

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy